Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A study to find out if 3 injections with a vaccine (given over the course of 30 days) to prevent infection with Clostridium difficile (C difficile) is safe and well tolerated in healthy people who were 50 to 85 years of age
Category & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06425090
Language: English
ViewDownloadPrint
A Study Investigating the Safety of a Clostridium difficile Vaccine in Subjects 65 to 85 Years of Age
Category & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06425090
Language: English
ViewDownloadPrint
Clostridium Difficile Vaccine Efficacy Trial (Clover)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 3
Medicine: PF-06425090
Language: English
ViewDownloadPrint
Clostridium difficile -rokotteen tehokkuustutkimus (Clover)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 3
Medicine: PF-06425090
Language: Finnish
ViewDownloadPrint
A Study to Measure Whether PF-06480605 is Safe and Effective in the Treatment of Moderate to Severe Ulcerative Colitis
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06480605
Language: English
ViewDownloadPrint
Clinical Study of a New Pneumococcal Vaccine in Adults 60 through 64 Years of Age
Category & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06482077
Language: English
ViewDownloadPrint
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint
A study of 20vPnC vaccine in healthy children – if it was safe and produced antibody responses against a germ called Streptococcus pneumoniae
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-06482077
Language: English
ViewDownloadPrint